{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:51:36Z","timestamp":1781679096924,"version":"3.54.5"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Acute pain has become increasingly prevalent in the United States due to an aging population, rising metabolic disease rates, and growth in surgical procedures. Opioids remain the primary treatment for moderate-to-severe acute pain but are associated with serious adverse events, including misuse, dependency, opioid use disorder, and overdose. In contrast, restrictive prescribing may result in undertreatment of acute pain and progression to chronic pain (\u201cchronification\u201d), generating additional long-term costs. As an accompanying analysis to our prior work on the increasing burden of acute pain in the wake of the opioid crisis, this study estimates the annual U.S. economic burden attributable to opioid-related serious adverse events and undertreatment of acute pain, including chronification. An economic analysis was performed to estimate direct healthcare costs and indirect productivity losses, with all values adjusted to 2024 U.S. dollars. The total annual economic burden was estimated at $425.0 billion (range: $164.5\u2013$1,215.5 billion). Direct costs were driven by dependency, misuse\/abuse, OUD, and chronic pain, while productivity losses were dominated by fatal overdoses and chronification. These findings highlight the substantial economic consequences of both opioid-related harms and inadequate pain management, demonstrating the urgent need for pain management strategies that adequately treat acute pain while minimizing the risk of serious adverse events.<\/jats:p>","DOI":"10.3389\/fpubh.2026.1824038","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:52:10Z","timestamp":1781675530000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The Economic burden of opioid-related serious adverse events and undertreatment of acute pain in the United States"],"prefix":"10.3389","volume":"14","author":[{"given":"James C.","family":"Hackworth","sequence":"first","affiliation":[{"name":"Tris Pharma","place":["Monmouth Junction, NJ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Schneider","sequence":"additional","affiliation":[{"name":"Avalon Health Economics","place":["Morristown, NJ, United States"]},{"name":"Avalon Health Economics","place":["Miami, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie L.","family":"Do Valle","sequence":"additional","affiliation":[{"name":"Avalon Health Economics","place":["Morristown, NJ, United States"]},{"name":"Avalon Health Economics","place":["Miami, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Fam","sequence":"additional","affiliation":[{"name":"Tris Pharma","place":["Monmouth Junction, NJ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ohsfeldt","sequence":"additional","affiliation":[{"name":"Texas A&M University","place":["College Station, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Offidani","sequence":"additional","affiliation":[{"name":"Tris Pharma","place":["Monmouth Junction, NJ, United States"]},{"name":"Clinical Epidemiology and Evaluative Sciences, Weill Cornell Medicine","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Potenziano","sequence":"additional","affiliation":[{"name":"Tris Pharma","place":["Monmouth Junction, NJ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1642035","DOI":"10.3389\/fpain.2025.1642035","article-title":"The burden of acute pain in the U.S. in the wake of the opioid crisis","volume":"6","author":"Hackworth","year":"2025","journal-title":"Front Pain Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jpain.2012.03.009","article-title":"The economic costs of pain in the United States","volume":"13","author":"Gaskin","year":"2012","journal-title":"J Pain"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1093\/pm\/pny099","article-title":"Postoperative pain trajectories and pain Chronification-an empirical typology of pain patients","volume":"19","author":"Althaus","year":"2018","journal-title":"Pain Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1097\/j.pain.0000000000001401","article-title":"When pain gets stuck: the evolution of pain chronification and treatment resistance","volume":"159","author":"Borsook","year":"2018","journal-title":"Pain"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11916-018-0666-8","article-title":"Chronification of pain: mechanisms, current understanding, and clinical implications","volume":"22","author":"Pak","year":"2018","journal-title":"Curr Pain Headache Rep"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1111\/pme.12528","article-title":"Associations of socioeconomic position and pain prevalence in the United States: findings from the National Health and nutrition examination survey","volume":"15","author":"Riskowski","year":"2014","journal-title":"Pain Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jpain.2006.12.003","article-title":"Comorbidity of obesity and pain in a general population: results from the southern pain prevalence study","volume":"8","author":"Hitt","year":"2007","journal-title":"J Pain"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00264-006-0130-y","article-title":"Obesity increases the likelihood of total joint replacement surgery among younger adults","volume":"31","author":"Harms","year":"2007","journal-title":"Int Orthop"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.2106\/jbjs.K.00820","article-title":"The influence of obesity on the complication rate and outcome of total knee arthroplasty: a meta-analysis and systematic literature review","volume":"94","author":"Kerkhoffs","year":"2012","journal-title":"J Bone Joint Surg Am"},{"key":"ref10","volume-title":"Obesity Rate Declining in U.S","author":"Witters","year":"2025"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.annemergmed.2015.11.033","article-title":"Emergency department prescription opioids as an initial exposure preceding addiction","volume":"68","author":"Butler","year":"2016","journal-title":"Ann Emerg Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jemermed.2020.07.016","article-title":"Predicting the transition to chronic pain 6 months after an emergency department visit for acute pain: a prospective cohort study","volume":"59","author":"Friedman","year":"2020","journal-title":"J Emerg Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1097\/j.pain.0000000000002653","article-title":"Rethinking the definition of chronic postsurgical pain: composites of patient-reported pain-related outcomes vs pain intensities alone","volume":"163","author":"Hofer","year":"2022","journal-title":"Pain"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"40iii","DOI":"10.1093\/rheumatology\/keg497","article-title":"The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors","volume":"42","author":"Stephens","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.drugalcdep.2016.12.002","article-title":"Providing chronic pain management in the \"fifth vital sign\" era: historical and treatment perspectives on a modern-day medical dilemma","volume":"173","author":"Tompkins","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"ref16","volume-title":"Understanding the Use of Medicines in the U.S. 2025: Evolving Standards of Care, Patient Access, and Spending","year":"2025"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1056\/NEJMp1904190","article-title":"No shortcuts to safer opioid prescribing","volume":"380","author":"Dowell","year":"2019","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain--United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1093\/pm\/pny307","article-title":"Challenges with implementing the Centers for Disease Control and Prevention opioid guideline: a consensus panel report","volume":"20","author":"Kroenke","year":"2019","journal-title":"Pain Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/pm\/pnx140","article-title":"Attitudes, beliefs, practices, and concerns among clinicians prescribing opioids in a large academic institution","volume":"19","author":"Ebbert","year":"2018","journal-title":"Pain Med"},{"key":"ref22","volume-title":"FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain","year":"2025"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1097\/aln.0000000000005460","article-title":"Suzetrigine, a nonopioid Na V 1.8 inhibitor for treatment of moderate-to-severe acute pain: two phase 3 randomized clinical trials","volume":"142","author":"Bertoch","year":"2025","journal-title":"Anesthesiology"},{"key":"ref24","volume-title":"FDA Issues New Guidance to Expand Non-Opioid Options for Chronic Pain, Curb Misuse","year":"2025"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain \u2014 United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"ref26","volume-title":"Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research","year":"2011"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"E115","DOI":"10.36076\/ppj\/2015.18.E115","article-title":"An updated assessment of utilization of interventional pain management techniques in the Medicare population: 2000\u20142013","volume":"18","author":"Manchikanti","year":"2015","journal-title":"Pain Physician"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"108350","DOI":"10.1016\/j.drugalcdep.2020.108350","article-title":"The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017","volume":"218","author":"Florence","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"ref29","volume-title":"DOSE-DIS Dashboard: Nonfatal Overdose Emergency Department and Inpatient Hospitalization Discharge Data","year":"2026"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/j.1526-4637.2010.00983.x","article-title":"Causes and consequences of inadequate management of acute pain","volume":"11","author":"Sinatra","year":"2010","journal-title":"Pain Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.15585\/mmwr.mm7015a1","article-title":"State-level economic costs of opioid use disorder and fatal opioid overdose\u2014United States, 2017","volume":"70","author":"Luo","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jsat.2019.08.010","article-title":"Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in new York City","volume":"106","author":"Behrends","year":"2019","journal-title":"J Subst Abus Treat"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e193676","DOI":"10.1001\/jamanetworkopen.2019.3676","article-title":"Expenditures and health care utilization among adults with newly diagnosed low Back and lower extremity pain","volume":"2","author":"Kim","year":"2019","journal-title":"JAMA Netw Open"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1526-4637.2011.01075.x","article-title":"Societal costs of prescription opioid abuse, dependence, and misuse in the United States","volume":"12","author":"Birnbaum","year":"2011","journal-title":"Pain Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ypmed.2019.02.018","article-title":"Prescription opioid misuse among middle-aged and older adults in the United States, 2015-2016","volume":"121","author":"Han","year":"2019","journal-title":"Prev Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jsat.2017.03.007","article-title":"Past-year prevalence of prescription opioid misuse among those 11 to 30years of age in the United States: a systematic review and meta-analysis","volume":"77","author":"Jordan","year":"2017","journal-title":"J Subst Abus Treat"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.dhjo.2018.12.001","article-title":"Prescription opioid behaviors among adults with and without disabilities\u2014United States, 2015-2016","volume":"12","author":"Lauer","year":"2019","journal-title":"Disabil Health J"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3109\/15360288.2015.1101641","article-title":"Economic burden of prescription opioid misuse and abuse: a systematic review","volume":"29","author":"Oderda","year":"2015","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.18553\/jmcp.2010.16.s1-b.9","article-title":"Empirical view of opioid dependence","volume":"16","author":"Ruetsch","year":"2010","journal-title":"J Manag Care Pharm"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"108019","DOI":"10.1016\/j.pharmthera.2021.108019","article-title":"Treatment of overdose in the synthetic opioid era","volume":"233","author":"Skolnick","year":"2022","journal-title":"Pharmacol Ther"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1186\/s12913-025-13095-9","article-title":"Healthcare utilization trends among patients with opioid use disorder in U.S. hospitals: an analysis of length of stay, total charges, and costs, 2005-2020","volume":"25","author":"Qeadan","year":"2025","journal-title":"BMC Health Serv Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/sla.0000000000002372","article-title":"The fifth vital sign: postoperative pain predicts 30-day readmissions and subsequent emergency department visits","volume":"266","author":"Hernandez-Boussard","year":"2017","journal-title":"Ann Surg"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"106136","DOI":"10.1016\/j.irle.2023.106136","article-title":"The effect of opioids on crime: evidence from the introduction of OxyContin","volume":"74","author":"Sim","year":"2023","journal-title":"Int Rev Law Econ"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/add.13729","article-title":"The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California","volume":"112","author":"Krebs","year":"2017","journal-title":"Addiction"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.fsisyn.2019.09.003","article-title":"The hidden costs of the opioid crisis and the implications for financial management in the public sector","volume":"1","author":"Ropero-Miller","year":"2019","journal-title":"Forensic Sci Int Synerg"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"E136","DOI":"10.1097\/jan.0000000000000552","article-title":"Perceived stressors and support in family caregivers of individuals with opioid use disorder","volume":"34","author":"Tyo","year":"2023","journal-title":"J Addict Nurs"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/j.pain.0000000000003056","article-title":"Co-occurrence of chronic pain and anxiety\/depression symptoms in U.S. adults: prevalence, functional impacts, and opportunities","volume":"165","author":"De La Rosa","year":"2024","journal-title":"Pain"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1080\/13696998.2025.2530863","article-title":"The NOPAIN Act: providing access and reimbursement for qualified non-opioid options for Medicare patients with potential implications for other patient populations","volume":"28","author":"Bour","year":"2025","journal-title":"J Med Econ."},{"key":"ref49","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jss.2025.04.033","article-title":"Association Between Inadequate Pain Control and Emergency Department Utilization in Trauma Patients","volume":"311","author":"Smith","year":"2025","journal-title":"J Surg Res."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s40122-025-00762-2","article-title":"Pain Group of the Chinese Society of Anesthesiology. The Impact of Opioid-Sparing Analgesia on Postoperative Pain and Recovery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"14","author":"Zhang","year":"2025","journal-title":"Pain Ther"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jpain.2015.05.002","article-title":"Estimates of pain prevalence and severity in adults: United States, 2012","volume":"16","author":"Nahin","year":"2015","journal-title":"J Pain."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3109\/15360280903544877","article-title":"Costs of opioid abuse and misuse determined from a Medicaid database","volume":"24","author":"McAdam-Marx","year":"2010","journal-title":"J Pain Palliat Care Pharmacother."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1001\/jama.290.18.2443","article-title":"Lost productive time and cost due to common pain conditions in the US workforce","volume":"290","author":"Stewart","year":"2003","journal-title":"JAMA."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1824038\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:52:12Z","timestamp":1781675532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1824038\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":53,"alternative-id":["10.3389\/fpubh.2026.1824038"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1824038","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"article-number":"1824038"}}